Dmitry Balyasny’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-17,299
Closed -$494K 2998
2026
Q1
$494K Buy
+17,299
New +$590K ﹤0.01% 2370
2025
Q1
Sell
-76,190
Closed -$2.33M 2779
2024
Q4
$2.33M Sell
76,190
-78,730
-51% -$2.53M ﹤0.01% 1623
2024
Q3
$4.34M Buy
+154,920
New +$3.82M 0.01% 1320
2023
Q3
Sell
-6,513
Closed -$321K 2244
2023
Q2
$321K Sell
6,513
-22,298
-77% -$1.03M ﹤0.01% 1972
2023
Q1
$1.19M Buy
+28,811
New +$1.2M ﹤0.01% 1675
2022
Q2
Sell
-196,954
Closed -$12.9M 2731
2022
Q1
$12.9M Buy
+196,954
New +$12.8M 0.04% 596
2021
Q4
Sell
-315,647
Closed -$22M 2220
2021
Q3
$22M Buy
+315,647
New +$24.3M 0.09% 311
2021
Q1
Sell
-156,524
Closed -$8.71M 1741
2020
Q4
$8.71M Buy
156,524
+136,834
+695% +$5.92M 0.05% 468
2020
Q3
$786K Buy
+19,690
New +$835K 0.01% 1042
2018
Q3
Sell
-8,174
Closed -$221K 1653
2018
Q2
$221K Sell
8,174
-7,379
-47% -$173K ﹤0.01% 1617
2018
Q1
$319K Buy
+15,553
New +$281K ﹤0.01% 1593
2017
Q4
Sell
-10,485
Closed -$235K 2047
2017
Q3
$235K Buy
+10,485
New +$237K ﹤0.01% 1635

Other funds holding ATRC

Dmitry Balyasny's ATRC Position: Q2 2026 in Review

Dmitry Balyasny sold out of AtriCure (ATRC) in Q2 2026, closing a stake of 17,299 shares — an estimated $494K sold.

Dmitry Balyasny first reported a position in ATRC in Q3 2017 and held it in 12 quarters. The position peaked at $22M in Q3 2021. 250 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Dmitry Balyasny reported no remaining AtriCure position as of Q2 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 17,299 AtriCure shares in Q2 2026, an estimated $494K.
  • Dmitry Balyasny first reported a position in AtriCure in Q3 2017 and held it in 12 quarters.
  • Dmitry Balyasny's AtriCure position peaked at $22M in Q3 2021.
  • 250 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.